Ebola Virus Bayesian Machine Learning Models Enable New in Vitro Leads

Ebola Virus Bayesian Machine Learning Models Enable New in Vitro Leads

Bibliographic Details
Main Authors:	Manu Anantpadma, Thomas Lane, Kimberley M. Zorn, Mary A. Lingerfelt, Alex M. Clark, Joel S. Freundlich, Robert A. Davey, Peter B. Madrid, Sean Ekins
Format:	Article
Language:	English
Published:	American Chemical Society 2019-01-01
Series:	ACS Omega
Online Access:	http://dx.doi.org/10.1021/acsomega.8b02948

Similar Items

Machine learning models identify molecules active against the Ebola virus in vitro [version 3; referees: 2 approved]
by: Sean Ekins, et al.
Published: (2017-01-01)

Machine learning models identify molecules active against the Ebola virus in vitro [version 1; referees: 2 approved]
by: Sean Ekins, et al.
Published: (2015-10-01)

Machine learning models identify molecules active against the Ebola virus in vitro [version 2; referees: 2 approved]
by: Sean Ekins, et al.
Published: (2016-01-01)

Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection.
by: Thomas R Lane, et al.
Published: (2019-11-01)

A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus [v1; ref status: indexed, http://f1000r.es/4qh]
by: Sean Ekins, et al.
Published: (2014-11-01)

A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus [v2; ref status: indexed, http://f1000r.es/4wt]
by: Sean Ekins, et al.
Published: (2014-12-01)

Interferon-γ Inhibits Ebola Virus Infection.
by: Bethany A Rhein, et al.
Published: (2015-01-01)

Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor
by: Qinghua Cui, et al.
Published: (2018-03-01)

Computational Approaches to Identify Molecules Binding to Mycobacterium tuberculosis KasA
by: Ana C. Puhl, et al.
Published: (2020-11-01)

Finding small molecules for the ‘next Ebola’ [v1; ref status: indexed, http://f1000r.es/542]
by: Sean Ekins, et al.
Published: (2015-02-01)

Finding small molecules for the ‘next Ebola’ [v2; ref status: indexed, http://f1000r.es/5lb]
by: Sean Ekins, et al.
Published: (2015-07-01)

Small molecules with antiviral activity against the Ebola virus [v1; ref status: indexed, http://f1000r.es/523]
by: Nadia Litterman, et al.
Published: (2015-02-01)

Combining Metabolite-Based Pharmacophores with Bayesian Machine Learning Models for Mycobacterium tuberculosis Drug Discovery.
by: Sean Ekins, et al.
Published: (2015-01-01)

Confirmation of high-throughput screening data and novel mechanistic insights into FXR-xenobiotic interactions by orthogonal assays
by: Jon Hamm, et al.
Published: (2022-01-01)

Automation of Infectious Focus Assay for Determination of Filovirus Titers and Direct Comparison to Plaque and TCID<sub>50</sub> Assays
by: Patrick T. Keiser, et al.
Published: (2021-01-01)

An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA Interactions
by: Daisy W. Leung, et al.
Published: (2015-04-01)

Essential Metabolites of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> and Their Mimics
by: Gyanu Lamichhane, et al.
Published: (2011-03-01)

Ebola Virus RNA in Semen from an HIV-Positive Survivor of Ebola
by: Lawrence J. Purpura, et al.
Published: (2017-04-01)

Adaptive Bayesian agents: Enabling distributed social networks
by: A. Potgieter, et al.
Published: (2006-03-01)

Post-Ebola sequelae among Ebola child survivors in Sierra Leone
by: Claudette Amuzu, et al.
Published: (2021-10-01)

Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors
by: Emmanuel Broni, et al.
Published: (2023-03-01)

The Thucydides Syndrome: Ebola Déjà Vu? (or Ebola Reemergent?)
by: P. E. Olson, et al.
Published: (1996-04-01)

Metabolic plasticity enables lifestyle transitions of Porphyromonas gingivalis
by: M. Fata Moradali, et al.
Published: (2021-05-01)

EBOLA FEVER
by: V. A. Markin, et al.
Published: (2016-12-01)

Correction to “Using Bibliometric Analysis and Machine Learning to Identify Compounds Binding to Sialidase-1”
by: Jennifer J. Klein, et al.
Published: (2021-06-01)

EBOLA
by: Tadeja Kotar
Published: (2014-12-01)

Ebola vaccination
by: Fitzgerald, F, et al.
Published: (2015)

Predicting Ebola Severity: A Clinical Prioritization Score for Ebola Virus Disease.
by: Mary-Anne Hartley, et al.
Published: (2017-02-01)

Implementing a DHIS2 Ebola virus disease module during the 2021 Guinea Ebola outbreak
by: Joel Montgomery, et al.
Published: (2022-05-01)

An Investigation of the Effect of Transfected Defective, Ebola Virus Genomes on Ebola Replication
by: Sophie J. Smither, et al.
Published: (2020-04-01)

Recommendations to enable drug development for inherited neuropathies: Charcot-Marie-Tooth and Giant Axonal Neuropathy [v2; ref status: indexed, http://f1000r.es/3am]
by: Lori Sames, et al.
Published: (2014-04-01)

Predicting Ebola infection: A malaria-sensitive triage score for Ebola virus disease.
by: Mary-Anne Hartley, et al.
Published: (2017-02-01)

Ébola (Enfermedad por el Virus del Ébola
by: Cristina Fernández Barrantes
Published: (2014-11-01)

Ebola/Athens Revisited
by: P.E. Olson, et al.
Published: (1998-03-01)

Learning Bayesian Networks That Enable Full Propagation of Evidence
by: Anthony C. Constantinou
Published: (2020-01-01)

The quest for effective Ebola treatment: Ebola VP35 is an evidence-based target for dsRNA drugs
by: William M Mitchell, et al.
Published: (2014-01-01)

Vaccines for Ebola
by: Editorial Article
Published: (2015-02-01)

Kenali Ebola
by: Asri Hendrawati
Published: (2015-09-01)

The cost of Ebola
by: Zoë Mullan
Published: (2015-08-01)

Etymologia: Ebola
Published: (2015-11-01)